Social cognition and prefrontal cognitive function in patients with epilepsy treated with eslicarbazepine acetate
<p><strong>Purpose</strong>: The purpose of this study was to evaluate the impact of treatment with eslicarbazepine acetate (ESL) on social cognition and prefrontal cognitive function in adults with partial onset seizures.</p><p><strong>Methods</strong>: A p...
Saved in:
Main Authors: | Laura Abraira (Author), Sanabria A (Author), Ortega G (Author), Quintana M (Author), Santamarina E (Author), Salas-Puig J (Author), Toledo M (Author) |
---|---|
Format: | Book |
Published: |
Journal of Neurology, Neurological Science and Disorders - Peertechz Publications,
2017-07-17.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comments on the Eslicarbazepine Acetate Section of the Article 'Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications'
by: Patricio Soares-, et al.
Published: (2010) -
Inhibitory Effect of Eslicarbazepine Acetate and S-Licarbazepine on Nav1.5 Channels
by: Theresa K. Leslie, et al.
Published: (2020) -
Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
by: Sunkaraneni S, et al.
Published: (2017) -
Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
by: Martyna Stefaniak, et al.
Published: (2022) -
Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias
by: Christopher D. Ma, et al.
Published: (2022)